Activity of Regorafenib in Combination With Chemotherapy in Patients With Advanced Biliary Tract Cancer

NCT02386397 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Digestive Cancer

Interventions

DRUG: Regorafenib
DRUG: GEMOX

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle